RESONATE-2: 7-year follow-up data

Name: EHA - Congress Site - CLL - Resonate 2
Uploaded: 2021-06-04T16:42:45.934Z

‌
‌

Prof. Paolo Ghia discusses the latest 7-year follow-up IMBRUVICA^® data in 1L CLL RESONATE-2 reinforces confidence in long-term survival with IMBRUVICA^®, including those with high-risk genetic features^[1]